Kenvue Inc. Kenvue Inc.

Kenvue Inc.

KVUE

Classifica tra le azioni #663
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Prezzo delle azioni
$19.29
Ultima sincronizzazione: 2026-10-20
Capitalizzazione di mercato
$37.05B
Variazione (1 giorno)
2.23%
Variazione (1 anno)
29.20%
Paese
US
Scambia Kenvue Inc. (KVUE)

Categoria

Consumer Defensive
Rapporto P/S per Kenvue Inc. (KVUE)
Rapporto P/S al October 2026 TTM: 2.25
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Kenvue Inc., il rapporto P/S attuale (TTM) è 2.25. Alla fine del 2023, era pari a 2.58.
Storico del rapporto P/S per Kenvue Inc. da 2019 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
2026 (TTM) 2.25 -14.31%
2024 2.62 1.82%
2023 2.58 -25.19%
2022 3.45 2.08%
2021 3.38 -3.90%
2020 3.51 -0.99%
2019 3.55 0.00%
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
4.28 90.49%
US
4.52 101.43%
FR
3.52 56.59%
US
6.75 200.80%
IN
2.45 8.94%
US